3 Reasons HAE is Risky and 1 Stock to Buy Instead
3 Profitable Stocks We Find Risky
BOSTON , June 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today...
BOSTON , June 2, 2026 /PRNewswire/ --Â Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 47th...
Haemonetics (HAE) Stock Is Up, What You Need To Know
Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)
3 Russell 2000 Stocks That Concern Us
3 Small-Cap Stocks We’re Skeptical Of
Haemonetics (NYSE:HAE) reported fiscal fourth-quarter revenue of $346 million, up 5% on a reported basis and 9% organically excluding CSL, as strength in its Plasma and Blood Management Technologies businesses...
Haemonetics (NYSE:HAE) Reports Upbeat Q1 CY2026